scholarly journals Nivolumab provides improved effectiveness and safety compared with docetaxel as a second-line treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis

2019 ◽  
Vol 8 (2) ◽  
pp. 629-642 ◽  
Author(s):  
Zheng Xu ◽  
Fengming Yi ◽  
Dongliang Yu ◽  
Jianjun Xu ◽  
Yiping Wei ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Meta Analysis ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung

scholarly journals Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Adrian D. Vickers ◽  
Katherine B. Winfree ◽  
Gebra Cuyun Carter ◽  
Urpo Kiiskinen ◽  
Min-Hua Jen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Meta Analysis ◽  
Small Cell ◽  
Second Line ◽  
Relative Efficacy ◽  
Small Cell Lung

scholarly journals First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis

2018 ◽  
Vol 10 (12) ◽  
pp. 6677-6694 ◽  
Author(s):  
Lisa M. Hess ◽  
Amy M. DeLozier ◽  
Fanni Natanegara ◽  
Xiaofei Wang ◽  
Victoria Soldatenkova ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Meta Analysis ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document